Immediate Impact
56 standout
Citing Papers
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
2025 Standout
Works of Steffen Pfeuffer being referenced
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020
2021
Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Steffen Pfeuffer | 341 | 150 | 171 | 51 | 561 | |
| Aurora Zanghì | 435 | 162 | 127 | 47 | 610 | |
| Leoni Rolfes | 267 | 131 | 115 | 39 | 491 | |
| Sibyl Wray | 426 | 169 | 209 | 57 | 600 | |
| Nuwan Kurukulasuriya | 356 | 86 | 79 | 37 | 536 | |
| Satoshi Yoshimura | 277 | 144 | 145 | 54 | 586 | |
| Paola Valentino | 299 | 134 | 143 | 25 | 465 | |
| Jai Perumal | 371 | 176 | 68 | 28 | 486 | |
| Francisco Gascón | 327 | 139 | 50 | 33 | 472 | |
| Pavel Štourač | 224 | 225 | 145 | 52 | 621 | |
| James K. Sheffield | 369 | 187 | 93 | 34 | 641 |
All Works
Login with ORCID to disown or claim papers
Loading papers...